Tyrosine Phosphorylation Regulates Maturation of Receptor Tyrosine Kinases
Open Access
- 1 May 2005
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 25 (9) , 3690-3703
- https://doi.org/10.1128/mcb.25.9.3690-3703.2005
Abstract
Constitutive activation of receptor tyrosine kinases (RTKs) is a frequent event in human cancer cells. Activating mutations in Fms-like tyrosine kinase 3 (FLT-3), notably, internal tandem duplications in the juxtamembrane domain (FLT-3 ITD), have been causally linked to acute myeloid leukemia. As we describe here, FLT-3 ITD exists predominantly in an immature, underglycosylated 130-kDa form, whereas wild-type FLT-3 is expressed predominantly as a mature, complex glycosylated 150-kDa molecule. Endogenous FLT-3 ITD, but little wild-type FLT-3, is detectable in the endoplasmic reticulum (ER) compartment. Conversely, cell surface expression of FLT-3 ITD is less efficient than that of wild-type FLT-3. Inhibition of FLT-3 ITD kinase by small molecules, inactivating point mutations, or coexpression with the protein-tyrosine phosphatases (PTPs) SHP-1, PTP1B, and PTP-PEST but not RPTPα promotes complex glycosylation and surface localization. However, PTP coexpression has no effect on the maturation of a surface glycoprotein of vesicular stomatitis virus. The maturation of wild-type FLT-3 is impaired by general PTP inhibition or by suppression of endogenous PTP1B. Enhanced complex formation of FLT-3 ITD with the ER-resident chaperone calnexin indicates that its retention in the ER is related to inefficient folding. The regulation of RTK maturation by tyrosine phosphorylation was observed with other RTKs as well, defines a possible role for ER-resident PTPs, and may be related to the altered signaling quality of constitutively active, transforming RTK mutants.Keywords
This publication has 57 references indexed in Scilit:
- Cotreatment with 17-Allylamino-Demethoxygeldanamycin and FLT-3 Kinase Inhibitor PKC412 Is Highly Effective against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3Cancer Research, 2004
- Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RETHuman Molecular Genetics, 2003
- Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitorsLeukemia, 2002
- Autoinhibitory mechanisms in receptor tyrosine kinasesFrontiers in Bioscience-Landmark, 2002
- Negative Regulation of Ros Receptor Tyrosine Kinase SignalingThe Journal of cell biology, 2001
- Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cellsEuropean Journal of Cell Biology, 2000
- Congenital Insulin Resistance Associated with a Conformational Alteration in a Conserved β-Sheet in the Insulin Receptor L1 DomainJournal of Biological Chemistry, 1999
- COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus.The Journal of cell biology, 1995
- A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populationsCell, 1991
- Transformation by v- sis Occurs by an Internal Autoactivation MechanismScience, 1989